Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards' Full Euro Launch Of Sapien XT Valve Helps Boost Numbers

This article was originally published in The Gray Sheet

Executive Summary

The European launch of Edwards Lifesciences' Sapien XT transcatheter valve drove a healthy jump in second-quarter revenue

You may also be interested in...



Chart: PARTNER II: Ready To Launch

Following well-received one-year results from its PARTNER study, Edwards announced Sept. 23 that it has finally received FDA go-ahead to begin the U.S. pivotal trial of its next-generation Sapien XT transcatheter valve.

Transcatheter Valve Data Gets Top-Line Attention At EuroPCR

Data from multiple registries presented last week at the EuroPCR conference in Paris offered no major trouble spots for European cardiologists looking to expand use of transcatheter aortic heart valves and U.S. doctors anxiously awaiting their approval

Edwards: Surgical Valve Sales Slow As Transcatheter Valve Ramps Up

Growth in Edwards Lifesciences surgical heart valve sales slowed in the first quarter due in part to pricing missteps, while the firm's nascent transcatheter heart valve business continued to pick up steam

Related Content

Topics

UsernamePublicRestriction

Register

MT029166

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel